Megan Wang, MD
NEW YORK—Prophylactic treatment with the neurokinin-1 receptor antagonist fosaprepitant, when combined with a standardized antiemetic regimen comprising dexamethasone and ondansetron, is superior to standard treatment alone in decreasing postoperative nausea and vomiting (PONV) and rescue antiemetic requirements in patients undergoing bariatric surgery, a new study has concluded.
“PONV is a common complication in any type of surgery, but in bariatric surgery it’s